Yasin Keshvargar
Lawyers
Filters
Ormat Technologies $338 million secondary offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
XPO Logistics cash tender offer
The tender offer involves 6.25% senior notes due 2025
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
RXO $355 million notes offering
The notes are being offering in connection with the intended spinoff of RXO
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares
Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
Alignment Healthcare $132.75 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Assertio $70 million convertible senior notes offering
The 6.5% notes are due 2027
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale